A Phase II Double-Blind Randomized Study of the Simultaneous Administration of Recombinant Human Interleukin-6 and Recombinant Human Granulocyte Colony-Stimulating Factor Following Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer

By Hochster H.   Speyer J.L.   Mandeli J.P.   Runowicz C.   Wadler S.   Berk G.   Wallach R.   Holland J.F.   for the New York Gynecologic Oncology Group  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 292-297

Elsevier

Access to resources Recommend Favorite

Cell Proliferation and Apoptosis in BRCA-Associated Hereditary Ovarian Cancer

By Levine D.A.   Federici M.G.   Reuter V.E.   Boyd J.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 431-434

Academic Press

Access to resources Recommend Favorite

Pneumocystis carinii Pneumonia in a Patient with Stage IV Ovarian Cancer

By Watanabe M.   Aoki Y.   Kurata H.   Tanaka K.  

Gynecologic Oncology, Vol. 87, Iss. 2, 2002-11 ,pp. : 225-227

Academic Press

Access to resources Recommend Favorite

Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal ³²P or intravenous cyclophosphamide and cisplatin - a Gynecologic Oncology Group study

By Naumann R. Wendel  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 33-34

Informa Healthcare

Access to resources Recommend Favorite

Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients

By Smith John   Vukelja Svetislava   Rabe Amy   Wentworth-Hartung Nicole   Koutrelakos Nicholas   Shao Spencer   Whittaker Thomas   Wang Yunfei   Asmar Lina   McDowell Diane   Mukhopadhyay Pralay   O’Shaughnessy Joyce  

Breast Cancer Research and Treatment, Vol. 142, Iss. 2, 2013-11 ,pp. : 381-388

Springer Publishing Company

Access to resources Recommend Favorite